Q3 FY2026 · ended Sep 30, 2026 · Revenue $29.34M, +29.9% YoY · Filed Nov 3, 2026
CeriBell, Inc. (CBLL) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $29.3 million and a net loss of $21.4 million. Free cash flow was -$13.2 million. As of Sep 30, 2026 it held $117.5 million in cash and investments and $1.6 million in total debt.
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- CBLL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Sunnyvale, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1861107
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- InMode Ltd. INMD
- CapsoVision, Inc CV
All 31 Electromedical & Electrotherapeutic Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $29.3M | $28.1M | $26.5M | $24.8M | $22.6M |
| Operating income | -$20.5M | -$20.0M | -$20.7M | -$14.6M | -$14.6M |
| Net income | -$21.4M | -$19.3M | -$19.7M | -$13.5M | -$13.5M |
| Diluted EPS | -$0.55 | -$0.51 | -$0.52 | -$0.36 | -$0.37 |
| Operating cash flow | -$13.1M | -$12.9M | -$19.3M | -$10.8M | -$11.1M |
| Free cash flow | -$13.2M | -$12.9M | -$19.4M | -$11.0M | -$11.5M |
| Total assets | $156.4M | $166.3M | $178.1M | $195.8M | $199.5M |
| Total liabilities | $38.8M | $38.0M | $37.3M | $40.5M | $35.4M |
| Stockholders' equity | $117.5M | $128.3M | $140.8M | $155.3M | $164.1M |
| Cash and investments | $117.5M | $129.3M | $141.2M | $159.3M | $168.5M |
| Total debt | $1.6M | $1.9M | $2.2M | $2.5M | $1.6M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 30, 2026 | Jul 28, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 2, 2026 | Jun 2, 2026 |
All 306 CeriBell, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.